Biology of Bladder Cancer (R21 Clinical Trial Optional)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save

Next deadline: Oct 16, 2021 (Full proposal)

Later deadlines: Oct 16, 2021 (Letter of inquiry), Nov 16, 2021 (Full proposal), Jan 16, 2022 (Letter of inquiry), Feb 16, 2022 (Full proposal), Feb 16, 2022 (Letter of inquiry), Mar 16, 2022 (Full proposal)

Grant amount: Up to US $275,000

Fields of work: Cancer/Oncology

Applicant type: Organizations

Funding uses: Biomedical

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE: 

  • Applications are due by 5pm submitter's local time on the following dates:
    • New applications are due on June 16, October 16, and February 16 annually.
    • Renewal, resubmission, and revision applications are due on July 16, November 16 and March 16.
  • Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.

This Funding Opportunity Announcement (FOA) solicits applications investigating the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem both in the United States and globally. Because of the high incidence and frequent tumor recurrence, bladder cancer exacts an outsized medical burden. While recent progress has been made in the molecular profiling of bladder cancers and identification of mutated genes, relatively little is known regarding the molecular mechanisms driving initiation, progression, and malignancy of bladder cancer. Furthermore, our understanding of biological processes of the normal bladder at the molecular, cell and organ levels is limited. Fundamental knowledge of how molecular and cellular functions of the bladder are altered in cancer will aid our understanding of bladder cancer biology and interventions. Applications that involve multidisciplinary teams and use clinical specimens or investigate both normal and cancer processes are encouraged.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed February 07, 2019 and last updated February 07, 2019